Doyle proposes $10M to expand use of electronic medical records ( m a cost perspective it's expensive to...)

Doyle proposes $10M to expand use of electronic medical records

m a cost perspective, it's expensive to maintain paper and move paper around. Once the [electronic] record is in place, it's pennies for that specific transaction," Christensen said.

Lincoln Brunner is a WTN contributing editor and can be reached at lincoln@wistechnology.com.

......

Full article >>>

Source:wistechnology.com By Lincoln Brunner 02/07/05

Page: 1 2 3
Related biology technology :

1. Doyle urges Legislature to support biofuels program
2. Doyle urges support of higher education spending
3. Doyle announces technology tax credits for Berbee
4. Doyle joins governors in support of stem cell bill
5. Doyle announces new energy, global warming policies
6. Doyle outlines spending for Medical College, UWM
7. Doyle wants sales tax applied to digital downloads
8. Doyle proposes $2M for venture capital center
9. Doyle seeks $30M for e-medical record adoption
10. Doyle says Congress should lift stem cell restrictions
11. Kanavas rips Doyle for taxing Internet

Post Your Comments:

(Date:11/5/2009)...l/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO...r ended September 30, 2009. The Company,s financia... ,, Third Quarter 2009 ,, The Company repo... the third quarter of 2009 as compared to a net lo...arter of 2008. ,, Net sales were $5.0 million ...

(Date:11/5/2009)...ire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX ), ...tor-based technologies to discover novel flavor in...upply industries, today provided a corporate updat...rter ended September 30, 2009. Revenues were $4.2...o $4.0 million for the third quarter of 2008, an i...

(Date:11/5/2009)...y firm BioSoteria announced that its Vice Presiden...d Professional in Learning and Performance™ ...aining and Development (ASTD) Certification Instit... of medical communications and health care trainin...t of the company,s online pharmacovigilance curric...

(Date:11/4/2009)...ccine Program must be stopped. Scott Miller and C... to Arms:2009 Edition" and the one-hour telev...Anthrax Vaccine Story" to inform the public a...vernment science turned into for-profit human anth.... It is available for world-wide licensing by mot...

[0] Transgenomic, Inc. Reports Third Quarter 2009 Results [0] SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS [0] BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification [0] Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing

...ober 6, 2008 at 3:00 p.m. EDT, BROOMFIELD, Colo.,... company developing genetically-targeted therapies...es, today announced that,Richard Brewer, the compa.... Michael Bristow, M.D., ARCA,s chairman and chief...Third Annual JMP Securities Healthcare Focus,Confe...

...erapy in U.S. to be Indicated ...ell Therapeutics, Inc. (CTI),(Nasdaq and MTA: CTIC...ntal,Biologics License Application (sBLA) with the...f Zevalin(R) ([90Y]-ibritumomab tiuxetan) as,conso...iously untreated,patients with follicular non-Hodg...

...No. 40/2008, - To OMX Nordic Exchange Copenhagen ...t of license to Roche Diagnostics for,use of the U...oprietary,LNA(TM) detection technology., Roche Di...alTime ready,qPCR assays with the Universal ProbeL...M) detection technology., "This extension of our ...

Other Biology Technology:ARCA biopharma to Present at JMP Securities Healthcare Focus Conference 2 ARCA biopharma to Present at JMP Securities Healthcare Focus Conference 3 ARCA biopharma to Present at JMP Securities Healthcare Focus Conference 4 ARCA biopharma to Present at JMP Securities Healthcare Focus Conference 5 Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 2 Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 3 Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 4 Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 5 Exiqon A/S Today Announces a Grant of License to Roche Diagnostics 2 Exiqon A/S Today Announces a Grant of License to Roche Diagnostics 3

ARCA biopharma to Present at JMP Securities Healthcare Focus Conference Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy Exiqon A/S Today Announces a Grant of License to Roche Diagnostics

(Date:11/5/2009)...of Biology Teachers (NABT) will recognize Leonard ...Naugatuck Valley Community College (NVCC) in Water...on Award during the NABT annual professional devel...n Denver, Colorado. , The Evolution Education Aw...ological Sciences,(AIBS) and Biological Sciences ...

(Date:11/5/2009)... been awarded a training grant in the amount of $2...its Integrative Graduation Education and Research ...grant to be awarded to Kent State. The grant, whic...stment Act of 2009, runs through 2014. , The gra...ent aquatic resource sensing (EARS). The purpose o...

(Date:11/4/2009)...tural science) , United States Using Less Wate...ay than it did 35 years ago, despite a 30 percent ...tly attributable to alternative cooling methods at...s. According to the latest USGS water use report, ... goes to cooling thermoelectric power plants. Irri...

Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2 Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2 USGS science picks 2 USGS science picks 3 USGS science picks 4 USGS science picks 5 USGS science picks 6 USGS science picks 7 BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 1 BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 2 BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 3 Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 1 Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 2 Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 3 Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 4 While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 1 While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 2 While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 3

[0] Biologists, educators recognize excellence in evolution education [0] Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing [1] USGS science picks

...pert at Johns Hopkins who has spent nearly three d...nfection known as Rocky Mountain spotted fever war...rial disease in Arizona is a growing and dangerous...infectious organisms beyond traditional state boun... England Journal of Medicine, the Hopkins patholog...

...h Institute have found that three bacterial specie... cancer--a discovery the researchers hope will lea...disease. , The findings also open the question of...l role. , The current discovery, reported in the J...that elevated levels of three particular bacteria ...

...nt a great advance for human health. It is based o...NOXIDE system, used in refrigeration towers of fac... be the focus for the proliferation of Legionnaire... team of INASMET-Tecnalia experts designed a refri...olated laboratory (P2 level). A wide range of tria...

Other Biology News:Infectious disease expert warns of spread of Rocky Mountain spotted fever 2 Infectious disease expert warns of spread of Rocky Mountain spotted fever 3 Forsyth scientists find three bacteria associated with oral cancer 2 Forsyth scientists find three bacteria associated with oral cancer 3

Infectious disease expert warns of spread of Rocky Mountain spotted fever Forsyth scientists find three bacteria associated with oral cancer Solution to 'legionella'

...TI-RNase is a protein ribonuclease inhibitor that ...atic RNase A-type enzymes. No inhibition is seen w...is distinct from human placental ribonuclease inhi...h RNase and does not release active RNase in the a...

RNaseOUT Recombinant Ribonuclease Inhibitor from Invitrogen

...e ChIP (Chemical Inkjet Printer) is a revolutionar...Protein Macroarray Analysis, developed in conjunct...ms. The strategy compliments established protocols...eins isoelectric point and apparent molecular weig...

...tural and Recombinant RNasin Ribonuclease Inhibito..., including the inhibition of eukaryotic RNases of...s inhibitory effect by noncovalently binding to RN...of RNasin Ribonuclease Inhibitor to RNase (e.g., R...

Biology Products:

ANTI-RNase from Ambion RNaseOUT Recombinant Ribonuclease Inhibitor from Invitrogen Chemical Inkjet Printer from Shimadzu Biotech Recombinant RNasin^® Ribonuclease Inhibitor from Promega

( m a cost perspective it's expensive to...)Doyle proposes $10M to expand use of electronic medical records